Hishikawa T, Kusunoki T, Tsuchiya K, Uzuka Y, Sakamoto T, Nagatake T, Matsumoto K
New Product Planning & Development Division, Takeda Chemical Industries, Ltd., Osaka, Japan.
Antimicrob Agents Chemother. 1991 Jun;35(6):1066-9. doi: 10.1128/AAC.35.6.1066.
Two beta-lactam antibiotics, cefazolin and cefmenoxime, were administered for 7 days to mice with pneumonia caused by Klebsiella pneumoniae by using dosage regimens that would simulate multiple dosing in usual clinical treatments at dosing intervals of 8 or 12 h. Viable numbers of the bacteria in the lungs were measured at 12- or 24-h intervals. The mathematical model established in a previous single-dose study was applied in this study to explain the time courses of the changes in bacterial count over 7 days. However, because the error in viable count measurements was larger than that in the previous study, the time course of the changes in mean viable count was not regular and the viable count reduction rate changed during multiple dosing, and therefore it was difficult to explain the time course by repeated application of the mathematical model described previously. This study suggests that the changes in pharmacokinetic and pharmacodynamic parameters during multiple dosing need to be considered.
使用头孢唑林和头孢甲肟这两种β-内酰胺类抗生素,以模拟常规临床治疗中每8或12小时多次给药的剂量方案,对肺炎克雷伯菌引起的肺炎小鼠给药7天。每隔12或24小时测量肺内细菌的活菌数。本研究应用在前一项单剂量研究中建立的数学模型来解释7天内细菌计数变化的时间过程。然而,由于活菌计数测量中的误差比前一项研究中的误差更大,平均活菌计数变化的时间过程不规则,且多次给药期间活菌计数降低率发生变化,因此难以通过重复应用先前描述的数学模型来解释时间过程。本研究表明,多次给药期间药代动力学和药效学参数的变化需要加以考虑。